abstract |
The present invention provides a novel α-substituted β-aminoethyl phosphonate and α-substituted β-aminovinyl phosphonate derivatives and apo (a), Lp (a), apo B, apo B related lipoproteins (low density lipoproteins). And ultra low density lipoproteins) and their use to reduce plasma levels of total cholesterol. |